Ind AS 36 Impairment of Assets: Cash-Generating Units, Value in Use & Reversals Guide

Executive Overview

Under Indian Accounting Standards (Ind AS), ensuring that corporate balance sheet assets are carried at no more than their recoverable economic value is a cornerstone of faithful financial representation. Governed by Ind AS 36, Impairment of Assets, the standard establishes an exhaustive, rigorous mechanism designed to detect, quantify, and account for the impairment of non-current operational assets—including Property, Plant and Equipment (Ind AS 16), Intangible Assets (Ind AS 38), Right-of-Use Assets (Ind AS 116), and Goodwill acquired in business combinations (Ind AS 103). For chief financial officers, corporate controllers, statutory auditors, and valuation specialists, mastering Ind AS 36 is vital because impairment write-downs represent non-cash charges that directly erode operating profits, equity net worth, and key solvency covenants demanded by institutional lenders.

The core philosophy of Ind AS 36 mandates that if the carrying amount of an asset (or group of assets) exceeds its Recoverable Amount, the asset is impaired, and the entity must immediately recognize an impairment loss in the Statement of Profit and Loss. The recoverable amount is defined as the higher of an asset's Fair Value Less Costs of Disposal (FVLCD) and its Value in Use (VIU). Where an individual asset does not generate cash inflows that are largely independent of those from other assets, the impairment test cannot be performed in isolation; the entity must aggregate assets into the smallest identifiable group known as a Cash-Generating Unit (CGU).

Executing Ind AS 36 testing requires rigorous financial modeling: constructing multi-year discounted cash flow (DCF) models, deriving market-participant pre-tax weighted average cost of capital (WACC) discount rates, allocating corporate overheads and goodwill across operating CGUs, and navigating strict rules regarding the reversal of impairment losses (including the absolute statutory ban on reversing goodwill impairment). Corporate accounting departments utilize integrated financial platforms like assureOffice to automate these intricate impairment workflows. Within this suite, assureFinancials automates DCF modeling, tracks CGU asset carrying values, and calculates the tax impact on deferred tax under Ind AS 12, while assurePractice centralizes third-party registered valuer reports and auditor documentation. This guide delivers a definitive, practitioner-grade exploration of Ind AS 36, detailing impairment indicators, CGU demarcation, VIU calculations, goodwill waterfall allocations, and disclosure standards.

Comparative Framework: Ind AS 36 vs Legacy AS 28 (Indian GAAP)

To ensure compliant financial reporting, accounting practitioners must understand the structural differences between Ind AS 36 and legacy Indian GAAP (AS 28). The table below delineates the core conceptual, computational, and disclosure variations between both standards.

Dimension	Legacy AS 28 (Indian GAAP)	Ind AS 36 (Indian Accounting Standards)
Core Philosophy	Identify assets whose carrying value exceeds net selling price or value in use.	Rigorous balance sheet recoverable amount testing; extensive disclosure rules.
Mandatory Annual Testing	No mandatory annual testing for goodwill unless impairment indicator exists.	Mandatory annual impairment testing for Goodwill and Indefinite Life Intangibles.
Scope: Leases	Finance lease assets tested under AS 19 / AS 28.	Explicitly covers Right-of-Use (ROU) Assets recognized under Ind AS 116.
Recoverable Amount	Higher of Net Selling Price and Value in Use.	Higher of Fair Value Less Costs of Disposal (FVLCD) and Value in Use (VIU).
Fair Value Measurement	Net selling price based on binding sales agreement or active market.	FVLCD measured strictly in accordance with the fair value hierarchy in Ind AS 113.
Discount Rate for VIU	Pre-tax discount rate reflecting market assessments of time value and risk.	Pre-tax rate reflecting current market assessments; explicit guidelines on unbiasing WACC.
Goodwill Impairment Allocation	Bottom-up or top-down test based on proportional historical asset costs.	Allocated to CGUs that are expected to benefit from synergies; capped at operating segments.
Reversal of Goodwill Impairment	Reversal permitted in rare exceptional circumstances if caused by external events.	ABSOLUTE PROHIBITION. An impairment loss recognized for Goodwill cannot be reversed.
Corporate Asset Allocation	Allocation to individual assets where practical; otherwise general pooling.	Strict allocation to CGUs on a reasonable and consistent basis; multi-tier testing.
Sensitivity Disclosures	Basic narrative disclosure of impairment losses recognized or reversed.	Mandatory quantitative sensitivity disclosures for key VIU assumptions (growth rates, WACC).

Detailed Statutory Architecture & Procedural Mechanics

1. Scope and Exempted Assets under Ind AS 36

Ind AS 36 applies to all non-current tangible and intangible assets, with specific exclusions governed by specialized standards. The scope is defined as follows:

• Assets Covered under Ind AS 36: Property, Plant and Equipment (Ind AS 16), Investment Property carried at cost (Ind AS 40), Intangible Assets (Ind AS 38), Goodwill acquired in a business combination (Ind AS 103), Right-of-Use Assets (Ind AS 116), Capital Work-in-Progress (CWIP), Intangible Assets under Development, and Investments in Subsidiaries, Joint Ventures, and Associates carried at cost in standalone financial statements (Ind AS 27).
• Explicit Scope Exclusions (Ind AS 36.2):
  1. Inventories (governed by net realizable value under Ind AS 2);
  2. Contract Assets and assets arising from costs to obtain/fulfill contracts (Ind AS 115);
  3. Deferred Tax Assets (governed by recovery probability under Ind AS 12);
  4. Assets arising from Employee Benefits (Ind AS 19);
  5. Financial Assets within the scope of Ind AS 109 (governed by the Expected Credit Loss / ECL model);
  6. Biological Assets related to agricultural activity measured at fair value less costs to sell (Ind AS 41); and
  7. Non-current assets classified as held for sale (Ind AS 105).

2. Mandatory Annual Impairment Testing vs Indicator-Based Testing

Ind AS 36 establishes a dual testing frequency framework:

1. Indicator-Based Testing (General Rule): Under Paragraph 9, an entity shall assess at the end of each reporting period whether there is any indication that an asset may be impaired. If any such indication exists, the entity shall estimate the recoverable amount of the asset. If no indicators exist, formal calculation of the recoverable amount is not required.
2. Mandatory Annual Testing (Without Regard to Indicators): Under Paragraph 10, irrespective of whether there is any indication of impairment, an entity must test the following assets for impairment annually:
   • Goodwill acquired in a business combination;
   • An Intangible Asset with an indefinite useful life (such as perpetual brand licenses or master trademarks); and
   • An Intangible Asset not yet available for use (capitalized in-house software or pharmaceutical clinical trials under development).
   The annual test may be performed at any time during an annual period, provided it is performed at the same time every year. Different CGUs may be tested at different times.

3. Internal and External Indicators of Impairment (Paragraph 12)

At each balance sheet date, management must document an evaluation of internal and external indicators:

• External Sources of Information:
  • Significant, unexpected decline in the asset's market value during the period, far exceeding normal aging;
  • Significant adverse changes in the technological, market, economic, or legal environment in which the entity operates;
  • Increase in market interest rates or return rates, which will increase the discount rate used in calculating value in use and materially decrease recoverable amount;
  • The carrying amount of the entity's net assets exceeds its market capitalization (a prime indicator for listed entities).
• Internal Sources of Information:
  • Evidence of physical obsolescence or physical damage to an asset;
  • Significant adverse changes in the extent to which an asset is used (e.g., plans to discontinue or restructure an operation, idle factory capacity);
  • Internal reporting indicating that the economic performance of an asset is, or will be, significantly worse than expected (e.g., cash flows or operating profits falling materially below budgeted projections).

4. Defining the "Recoverable Amount"

The Recoverable Amount of an asset or CGU is the higher of its Fair Value Less Costs of Disposal (FVLCD) and its Value in Use (VIU):

Recoverable Amount = Max [ Fair Value Less Costs of Disposal, Value in Use ]

Operational Efficiency Rule: It is not always necessary to determine both an asset's FVLCD and its VIU. If either of these amounts exceeds the asset's carrying amount, the asset is not impaired, and it is not necessary to estimate the other amount (Ind AS 36.19).

5. Fair Value Less Costs of Disposal (FVLCD)

FVLCD reflects the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date under Ind AS 113, less incremental direct costs attributable to the disposal (legal fees, stamp duty, transaction taxes, removal costs, and direct costs of bringing the asset into condition for sale). Restructuring costs and employee termination benefits resulting from the sale are excluded if the entity is not yet committed to a formal plan.

6. Value in Use (VIU): Cash Flow Forecasting and Discount Rates

Value in Use is the present value of the estimated future cash flows expected to be derived from an asset or CGU. Under Ind AS 36.30 to 36.57, VIU calculations must adhere to strict modeling disciplines:

• Cash Flow Horizon: Projections must be based on reasonable, supportable assumptions approved by management, covering a maximum period of five (5) years, unless a longer period can be justified. Projections beyond 5 years must be extrapolated using a steady or declining growth rate that does not exceed the long-term average growth rate for the products, industries, or country.
• Permissible Inflows and Outflows: Cash flows include: (a) projections of cash inflows from the continuing use of the asset; (b) projections of cash outflows necessarily incurred to generate the inflows (including day-to-day maintenance); and (c) net cash flows to be received for the disposal of the asset at the end of its useful life.
• Strict Exclusions from VIU Cash Flows: Under Ind AS 36.44, cash flow projections must strictly exclude:
  1. Future cash outflows or related cost savings/benefits from a future restructuring to which the entity is not yet committed; and
  2. Future cash outflows or inflows expected to arise from improving or enhancing the asset's performance (uncommitted capital expenditure). Projections must reflect the asset in its current condition.
  3. Financing cash flows (interest expense, principal repayments) and income tax receipts or payments (as the discount rate is applied on a pre-tax basis).
• The Discount Rate: Must be a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which future cash flow estimates have not been adjusted. In practice, entities start with the post-tax Weighted Average Cost of Capital (WACC) and derive the mathematically consistent pre-tax rate.

7. Concept of Cash-Generating Unit (CGU)

Under Ind AS 36.6, a Cash-Generating Unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. Identification of a CGU involves professional judgment:

• If an active market exists for the output produced by an asset or group of assets, that asset or group shall be identified as a CGU, even if some or all of the output is used internally.
• CGUs must be identified consistently from period to period for the same asset or types of assets, unless a change is justified.

8. Allocation of Impairment Loss across CGU Assets (Waterfall Approach)

When an impairment loss is recognized for a CGU, Paragraph 104 dictates a strict sequential "waterfall" allocation:

1. Step 1: First, reduce the carrying amount of any Goodwill allocated to the CGU to zero.
2. Step 2: Next, allocate the remaining impairment loss to the other assets of the CGU pro rata on the basis of the relative carrying amount of each asset in the CGU.
3. Floor Limitation (Paragraph 105): In allocating an impairment loss pro rata, the carrying amount of an individual asset shall not be reduced below the highest of:
   • Its Fair Value Less Costs of Disposal (if measurable);
   • Its Value in Use (if determinable); and
   • Zero.
   Any excess impairment that cannot be allocated to an asset due to this floor must be re-allocated pro rata to the other eligible assets of the unit.

9. Reversal of Impairment Losses: PPE vs Goodwill

Under Paragraph 114, an entity must assess at each balance sheet date whether there is an indication that an impairment loss recognized in prior periods may no longer exist or may have decreased. If such indicators exist, the entity re-estimates the recoverable amount:

• Reversal for Tangible & Intangible Assets: Allowed only if there has been a change in the estimates used to determine the recoverable amount since the last impairment loss was recognized. Strict Ceiling (Ind AS 36.117): The increased carrying amount of an asset attributable to a reversal shall not exceed the carrying amount that would have been determined (net of amortization or depreciation) had no impairment loss been recognized in prior years.
• Goodwill Reversal Absolute Prohibition (Paragraph 124): "An impairment loss recognized for goodwill shall not be reversed in a subsequent period." Any subsequent increase in recoverable amount of a previously impaired business acquisition is treated as internally generated goodwill, which is prohibited from recognition under Ind AS 38.

7 In-Depth Practical Case Studies & Numerical Illustrations

Case Study 1: Standalone Manufacturing Plant (Recoverable Amount Determination)

Context & Facts: Bharat Cement Industries Ltd owns a dedicated clinker grinding plant in Rajasthan. As on 31st March 2025, the plant's carrying amount on the balance sheet is ₹120,00,00,000 (₹120 Crore). Due to a sudden ban on local limestone quarrying, clinker production dropped 40%, triggering an impairment indicator under Paragraph 12. Management engaged registered independent valuers to calculate the Recoverable Amount:

• Fair Value Less Costs of Disposal (FVLCD): An independent valuer assessed the plant's open-market exit value at ₹95,00,00,000. Decommissioning, site clearing, legal and broker transaction costs are estimated at ₹5,00,00,000. Net FVLCD = ₹95 Cr - ₹5 Cr = ₹90,00,00,000 (₹90 Crore).
• Value in Use (VIU): Finance teams modeled discounted 5-year operating cash flows from grinding imported clinker, resulting in a present value of ₹98,00,00,000 (₹98 Crore) using a pre-tax WACC of 13.5%.

Step-by-Step Accounting Treatment:

1. Recoverable Amount: Higher of FVLCD (₹90 Cr) and VIU (₹98 Cr) = ₹98,00,00,000.
2. Impairment Loss Calculation:
   Carrying Amount: ₹120,00,00,000
   Less: Recoverable Amount: (₹98,00,00,000)
   Impairment Loss to be Recognized: ₹22,00,00,000 (₹22 Crore).
3. Journal Entry on 31st March 2025: Impairment Loss (Profit & Loss) Dr. ₹22,00,00,000 To Accumulated Impairment (PPE) ₹22,00,00,000 (Being impairment loss recognized on clinker grinding plant under Ind AS 36)
4. Prospective Depreciation Impact: The revised carrying amount of ₹98 Crore is depreciated prospectively over the remaining useful life of the plant under Ind AS 16. Bharat Cement tracks this asset write-down in assureFinancials.

Case Study 2: Identification of Cash-Generating Units in an Integrated Retail Chain

Context & Facts: QuickMart Supermarkets Ltd operates 150 retail grocery stores across India. It also owns 5 regional distribution warehouses that procure goods in bulk and deliver them to stores. Store No. 42 in South Delhi has incurred persistent operating losses for three consecutive years due to intense local competition. The store assets (leasehold improvements, POS equipment, refrigeration chillers, ROU asset under Ind AS 116) have a carrying value of ₹6,00,00,000. Management argues that Store No. 42 cannot be tested in isolation because it relies on the centralized regional warehouse and advertising brand of QuickMart.

Analysis under Ind AS 36.68:

• Under Paragraph 68, if an active market exists for the output of an asset or group of assets, it constitutes a CGU.
• Store No. 42 generates its own customer footfall and registers independent retail sales revenues. Its cash inflows are directly identifiable and largely independent of cash inflows from other stores.
• The existence of shared centralized warehouses and corporate marketing does not destroy the store's independent cash-generating capability; warehouse costs can be allocated on a reasonable management transfer-pricing basis.
• Conclusion: Store No. 42 is an independent Cash-Generating Unit (CGU). It must be tested for impairment individually. Management cannot mask Store No. 42's economic impairment by pooling it into the profitable North India Regional Division. QuickMart performs an individual DCF test for Store No. 42, recognizing an impairment of ₹1.8 Crore against its ROU assets.

Case Study 3: Value in Use (VIU) DCF Modeling and Pre-Tax WACC Derivation

Context & Facts: Zenon Solar Power Ltd operates a 50 MW solar installation. As on 31st March 2025, the solar park has a carrying value of ₹210,00,00,000 (₹210 Crore) with 15 years of remaining useful life. Due to grid curtailment issues, the company assesses VIU over a 5-year explicit forecast period plus terminal value. The financial parameters are:

• Year 1 Cash Flow: ₹28,00,00,000; Year 2: ₹30,00,00,000; Year 3: ₹31,00,00,000; Year 4: ₹32,00,00,000; Year 5: ₹33,00,00,000.
• Long-Term Steady Growth Rate after Year 5: 2.0% per annum.
• Post-Tax WACC: Cost of Equity 14.0% (Weight 40%), Post-Tax Cost of Debt 7.5% (Weight 60%). Post-Tax WACC = (14% * 0.4) + (7.5% * 0.6) = 5.6% + 4.5% = 10.1%.
• Applicable Corporate Tax Rate: 25.168% (Section 115BAA). Derived Pre-Tax WACC = 10.1% / (1 - 0.25168) = 13.50%.

Mathematical Discounting Model:

Period	Forecast Cash Flow	Discount Factor (13.50%)	Present Value (PV)
Year 1 (FY 2025-26)	₹28,00,00,000	0.8811	₹24,67,08,000
Year 2 (FY 2026-27)	₹30,00,00,000	0.7763	₹23,28,90,000
Year 3 (FY 2027-28)	₹31,00,00,000	0.6839	₹21,20,09,000
Year 4 (FY 2028-29)	₹32,00,00,000	0.6026	₹19,28,32,000
Year 5 (FY 2029-30)	₹33,00,00,000	0.5309	₹17,51,97,000
Terminal Value (TV)	₹33 Cr * 1.02 / (0.135 - 0.02) = ₹292.69 Cr	0.5309	₹155,39,01,200
Total Value in Use (VIU)	—	—	₹261,35,37,200 (₹261.35 Cr)

Because the VIU of ₹261.35 Crore exceeds the carrying value of ₹210 Crore, the asset is not impaired. No impairment loss is recognized. Zenon Solar stores this valuation workbook in assureFinancials for statutory auditor inspection.

Case Study 4: Goodwill Allocation and Multi-Asset CGU Impairment (Waterfall Breakdown)

Context & Facts: Global Pharma Corp acquired BioCure Formulations three years ago. The acquired business constitutes an operating CGU. As on 31st March 2025, the CGU's assets disclose the following carrying amounts:

• Goodwill from Business Combination: ₹30,00,00,000 (₹30 Crore).
• Patented Drug Formulation Molecule: ₹40,00,00,000 (₹40 Crore).
• Specialized Manufacturing Facility (PPE): ₹50,00,00,000 (₹50 Crore).
• Total CGU Carrying Amount: ₹120,00,00,000 (₹120 Crore).

Following the loss of a major international patent litigation, generic competition entered the market. An impairment test as on 31st March 2025 determines that the CGU's Recoverable Amount is ₹70,00,00,000 (₹70 Crore). The fair value less costs of disposal of the Manufacturing Facility can be independently verified at ₹42,00,00,000.

Step-by-Step Waterfall Allocation under Paragraph 104:

1. Total Impairment Loss: Carrying Amount (₹120 Cr) - Recoverable Amount (₹70 Cr) = ₹50,00,00,000 (₹50 Crore).
2. Step 1 (Goodwill Write-Down):
   Entire allocated Goodwill of ₹30 Crore is written down to Zero (₹0).
   Remaining Unallocated Impairment Loss = ₹50 Cr - ₹30 Cr = ₹20,00,00,000 (₹20 Crore).
3. Step 2 (Pro-Rata Allocation to Remaining Assets):
   Remaining non-goodwill assets: Patent (₹40 Cr) + PPE (₹50 Cr) = ₹90 Crore total.
   Patent Pro-Rata Share = 40/90 * ₹20 Cr = ₹8,88,88,889.
   PPE Pro-Rata Share = 50/90 * ₹20 Cr = ₹11,11,11,111.
4. Step 3 (Applying Floor Limit under Paragraph 105):
   Preliminary PPE Carrying Amount after allocation: ₹50 Cr - ₹11.11 Cr = ₹38.89 Crore.
   However, Paragraph 105 mandates that an asset cannot be reduced below its FVLCD (₹42 Crore).
   Maximum Impairment permissible on PPE = ₹50 Cr - ₹42 Cr = ₹8,00,00,000.
   The unallocated excess impairment of ₹3,11,11,111 (₹11.11 Cr - ₹8.00 Cr) must be re-allocated to the Patent.
5. Final Allocation Table:

   Asset	Pre-Impairment Carrying Value	Allocated Impairment Loss	Post-Impairment Carrying Value
   Goodwill	₹30,00,00,000	₹30,00,00,000 (100% wiped out)	₹0
   Patent Molecule	₹40,00,00,000	₹8.89 Cr + ₹3.11 Cr = ₹12,00,00,000	₹28,00,00,000
   Manufacturing PPE	₹50,00,00,000	₹8,00,00,000 (Capped at FVLCD floor)	₹42,00,00,000
   Total CGU	₹120,00,00,000	₹50,00,00,000	₹70,00,00,000

The entire ₹50 Crore impairment is debited to P&L. Global Pharma records these allocations inside assureFinancials.

Case Study 5: Reversal of PPE Impairment Loss (Historical Cost Ceiling)

Context & Facts: Precision Engineering Ltd acquired an automated forging press on 1st April 2021 for ₹10,00,00,000 (₹10 Crore), depreciated under SLM over 10 years (₹1 Crore/year). On 31st March 2023 (after 2 years of use), carrying value was ₹8,00,00,000. Due to a major automotive slump, the company recognized an impairment loss of ₹2,40,00,000, reducing carrying value to its recoverable amount of ₹5,60,00,000. The remaining useful life was 8 years, resulting in revised depreciation of ₹70,00,000 per year.

On 31st March 2025 (after 2 further years), carrying value is ₹5,60,00,000 - (2 * ₹70 Lakh) = ₹4,20,00,000. Due to an export boom, the market has recovered dramatically, and an updated valuation assesses the press's Recoverable Amount at ₹7,50,00,000. Management proposes reversing the entire impairment to recognize the asset at ₹7.5 Crore.

Reversal Computation under Paragraph 117:

• Under Paragraph 117, the increased carrying amount attributable to a reversal shall not exceed the carrying amount that would have been determined (net of depreciation) had no impairment loss been recognized in prior years.
• Historical Cost Baseline (Without Any Impairment):
  • Original Cost on 1st April 2021: ₹10,00,00,000.
  • 4 Years of Historical Depreciation (4 * ₹1 Crore): (₹4,00,00,000).
  • Ceiling Carrying Amount as on 31st March 2025: ₹6,00,00,000 (₹6 Crore).
• Determination of Reversal:
  • Current Carrying Amount: ₹4,20,00,000.
  • Assessed Recoverable Amount: ₹7,50,00,000.
  • Maximum Permissible Carrying Value: Capped at the ceiling of ₹6,00,00,000.
  • Permissible Impairment Reversal: ₹6,00,00,000 - ₹4,20,00,000 = ₹1,80,00,000 (₹1.8 Crore).
  • The excess ₹1.5 Crore (₹7.5 Cr - ₹6.0 Cr) represents an unearned revaluation surplus and cannot be recognized.
• Journal Entry on 31st March 2025: Accumulated Impairment (PPE) Dr. ₹1,80,00,000 To Reversal of Impairment (P&L) ₹1,80,00,000 (Being reversal of impairment recognized in P&L up to depreciated historical cost ceiling)

Case Study 6: Corporate Asset Allocation across Multiple Operating CGUs

Context & Facts: Matrix Infotech Ltd operates two distinct operating cash-generating units: CGU-Alpha (Enterprise Software Services, carrying value ₹80 Crore) and CGU-Beta (Fintech Cloud Hosting, carrying value ₹120 Crore). Matrix Infotech owns a corporate headquarters tower in Bengaluru with a carrying value of ₹40,00,00,000 (₹40 Crore). The headquarters does not generate independent cash inflows. Due to tech sector layoffs, an impairment indicator arises. Matrix must test both CGUs and the corporate headquarters for impairment.

Allocation & Testing Mechanics under Paragraph 102:

1. Allocation on a Reasonable and Consistent Basis: Under Ind AS 36.102, corporate assets must be allocated to CGUs on a pro-rata basis if a reasonable basis exists (e.g., relative carrying values or headcount):
   • CGU-Alpha Allocation (80/200 * ₹40 Cr): ₹16,00,00,000. Total Alpha Base = ₹80 Cr + ₹16 Cr = ₹96,00,00,000.
   • CGU-Beta Allocation (120/200 * ₹40 Cr): ₹24,00,00,000. Total Beta Base = ₹120 Cr + ₹24 Cr = ₹144,00,00,000.
2. Testing CGU-Alpha: Recoverable amount of CGU-Alpha is assessed at ₹105 Crore. Because ₹105 Cr > ₹96 Cr, CGU-Alpha and its allocated headquarters share are not impaired.
3. Testing CGU-Beta: Recoverable amount of CGU-Beta is assessed at ₹130 Crore.
   Carrying Value (₹144 Cr) > Recoverable Amount (₹130 Cr) = Impairment Loss of ₹14,00,00,000.
4. Allocation of Loss: The ₹14 Crore loss is allocated pro-rata between CGU-Beta's operational assets (₹120 Cr) and its allocated headquarters portion (₹24 Cr):
   • Loss to CGU-Beta Operating Assets: 120/144 * ₹14 Cr = ₹11,66,66,667.
   • Loss to Corporate Headquarters: 24/144 * ₹14 Cr = ₹2,33,33,333.

Matrix Infotech recognizes ₹11.67 Crore impairment against CGU-Beta assets and ₹2.33 Crore against the corporate headquarters building.

Case Study 7: Impact of Impairment on Deferred Taxes under Ind AS 12

Context & Facts: In Case Study 1, Bharat Cement recognized an impairment loss of ₹22,00,00,000 on its plant, reducing its accounting carrying value from ₹120 Crore to ₹98 Crore on 31st March 2025. For income tax purposes under Section 32 of the Income-tax Act, an accounting impairment is a non-cash provision that is completely disallowed; tax depreciation continues to be calculated on the tax written-down value (WDV). The tax WDV of the plant on 31st March 2025 is ₹110,00,00,000 (₹110 Crore). The applicable corporate tax rate is 25.168%.

Deferred Tax Interplay under Ind AS 12:

• Carrying Amount of Asset (Accounting Books): ₹98,00,00,000.
• Tax Base of Asset (Income-tax WDV): ₹110,00,00,000.
• Temporary Difference: Carrying Amount (₹98 Cr) < Tax Base (₹110 Cr) = Deductible Temporary Difference of ₹12,00,00,000.
• Deferred Tax Asset (DTA) Recognition: 25.168% of ₹12,00,00,000 = ₹3,02,01,600.
• Net P&L Impact:
  Pre-Tax Impairment Loss: (₹22,00,00,000)
  Deferred Tax Income Recognized (DTA): +₹3,02,01,600
  Net Post-Tax Impact on Reported Profits: (₹18,97,98,400).

Corporate finance synchronizes these tax entries automatically through assureFinancials, preventing misstatements in Schedule III tax expense notes.

10-Step Ind AS 36 Impairment Testing & Audit Verification Framework

To withstand intense technical scrutiny by statutory audit firms, the National Financial Reporting Authority (NFRA), and SEBI, corporate accounting teams must execute the following 10-step impairment testing protocol.

Stage	Procedural Mandate	Statutory Citation	Critical Operational Risk / Audit Trap	assureOffice Workflow Integration
Step 1	Annual Testing Mandate Screening	Ind AS 36.10	Failing to test Goodwill or indefinite life intangibles annually without indicators.	Tag annual mandatory testing assets in assureFinancials.
Step 2	Indicator Evaluation Documentation	Ind AS 36.12	Omitting formal documentation of internal/external indicators for audit defense.	Generate annual indicator checklists in assurePractice.
Step 3	CGU Demarcation Audit	Ind AS 36.68	Pooling loss-making retail stores into broader regions to hide impairments.	Maintain verified CGU asset mappings in assureFinancials.
Step 4	Cash Flow Forecast Normalization	Ind AS 36.44	Including uncommitted restructuring savings or enhancement capex in VIU.	Model compliant baseline DCF budgets via assureFinancials.
Step 5	WACC Discount Rate Derivation	Ind AS 36.55	Using post-tax WACC directly on pre-tax cash flows; mathematical distortion.	Derive verified pre-tax discount rates in assureFinancials.
Step 6	FVLCD Independent Valuation	Ind AS 113 & Ind AS 36.28	Relying on informal broker quotes; ignoring mandatory registered valuer reports.	Archive registered valuer dossiers in assurePractice.
Step 7	Goodwill Waterfall Allocation	Ind AS 36.104	Allocating impairment pro-rata to tangible assets before writing off Goodwill to zero.	Execute automated Paragraph 104 waterfall in assureFinancials.
Step 8	Asset Floor Limit Verification	Ind AS 36.105	Reducing individual asset carrying amounts below measurable FVLCD or zero.	Enforce Paragraph 105 floor limits inside assureFinancials.
Step 9	Reversal Ceiling Check	Ind AS 36.117 & 36.124	Reversing goodwill impairment (strictly barred) or exceeding depreciated cost.	Apply historical cost ceiling filters in assureFinancials.
Step 10	Quantitative Sensitivity Disclosures	Ind AS 36.134	Omitting sensitivity analysis on growth rates and discount rates in Note 34.	Auto-generate Schedule III sensitivity disclosure tables via assureFinancials.

Integrating assureOffice Ecosystem for Financial Reporting Governance

Maintaining institutional compliance across multi-entity corporate structures requires continuous synchronization between valuation modeling, financial reporting, and statutory audit documentation. The assureOffice suite equips corporate finance departments with integrated tools:

• assureFinancials: Operates as the core financial statement engineering system. It automates 5-year discounted cash flow modeling, derives mathematically consistent pre-tax WACC discount rates, calculates Goodwill waterfall write-downs under Paragraph 104, enforces Paragraph 105 asset floors, models Ind AS 12 deferred tax offsets, and generates audit-ready Schedule III Notes including quantitative sensitivity disclosures.
• assurePractice: Centralizes the statutory audit engagement repository. It archives independent registered valuer reports, tracks annual mandatory impairment testing calendars for goodwill and indefinite life intangibles, and stores management representation letters.
• assureTax: Harmonizes book impairment charges with income tax computations, ensuring that accounting impairment provisions are added back under Section 37(1) in Form 3CD Clause 21, while maintaining accurate tax WDV schedules under Section 32.
• assureNotice: Monitors regulatory filings and accounting queries from the National Financial Reporting Authority (NFRA), Registrar of Companies (ROC), and SEBI, tracking compliance dockets and response deadlines.

16 Practical Practitioner FAQs with Authoritative Answers

1. What is the fundamental objective of Ind AS 36?

The objective of Ind AS 36 is to prescribe the procedures an entity applies to ensure that its assets are carried at no more than their recoverable amount, and to prescribe when an impairment loss should be recognized or reversed.

2. What is the definition of 'Recoverable Amount' under Ind AS 36?

The recoverable amount of an asset or cash-generating unit is the higher of its Fair Value Less Costs of Disposal (FVLCD) and its Value in Use (VIU).

3. Which assets must be tested for impairment annually regardless of indicators?

Under Paragraph 10, Goodwill acquired in a business combination, intangible assets with indefinite useful lives, and intangible assets not yet available for use must be tested for impairment annually.

4. What is a Cash-Generating Unit (CGU)?

A CGU is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

5. Can future uncommitted restructurings be included in Value in Use cash flow projections?

No. Under Ind AS 36.44, future cash flows from restructurings to which the entity is not yet committed, or capital expenditures that improve or enhance an asset's performance, must be strictly excluded.

6. What discount rate must be used in calculating Value in Use?

The discount rate must be a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the asset for which future cash flows have not been adjusted.

7. What is the sequential waterfall for allocating an impairment loss to a CGU?

Under Paragraph 104, the impairment loss is first allocated to reduce the carrying amount of any goodwill allocated to the CGU to zero, and then allocated pro-rata to the other assets based on relative carrying amounts.

8. What is the floor limit for allocating an impairment loss to an individual asset under Paragraph 105?

An individual asset's carrying value cannot be reduced below the highest of its Fair Value Less Costs of Disposal, its Value in Use (if determinable), and zero.

9. Can an impairment loss recognized for Goodwill be reversed in a subsequent period?

No. Under Paragraph 124 of Ind AS 36, an impairment loss recognized for Goodwill cannot be reversed under any circumstances.

10. Under what conditions can an impairment loss on PPE be reversed?

An impairment loss on PPE can be reversed only if there has been a change in the estimates used to determine the recoverable amount since the last impairment was recognized, subject to the depreciated historical cost ceiling.

11. What is the historical cost ceiling for reversing an impairment loss on an asset?

Under Paragraph 117, the increased carrying amount cannot exceed the carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized in prior years.

12. How does an impairment loss affect future depreciation charges?

Following the recognition or reversal of an impairment loss, the depreciation charge for the asset is adjusted prospectively over its remaining useful life to allocate its revised carrying amount.

13. Does market capitalization falling below net asset value trigger an impairment test?

Yes. Under Paragraph 12(d), if the carrying amount of an entity's net assets exceeds its market capitalization, it is an explicit external indicator of impairment, requiring a formal recoverable amount calculation.

14. Are Right-of-Use (ROU) assets under Ind AS 116 covered under Ind AS 36?

Yes. ROU assets recognized on the balance sheet under Ind AS 116 are subject to impairment testing under Ind AS 36 either individually or as part of a CGU.

15. How does an accounting impairment loss impact deferred taxes under Ind AS 12?

Because accounting impairment reduces the carrying amount while the tax base remains unchanged, it creates or increases a deductible temporary difference, resulting in the recognition of a Deferred Tax Asset (DTA) if future taxable profits are probable.

16. What sensitivity disclosures are mandatory for CGUs containing goodwill?

Ind AS 36.134 mandates disclosing the key assumptions used in VIU models (such as discount rates and terminal growth rates), the period of projections, and quantitative sensitivity analyses showing the amount by which assumptions must change for recoverable amount to equal carrying amount.